-
ODTC Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Odonate Therapeutics (ODTC)
Company Profile
Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 95.74 mm | 95.74 mm | 95.74 mm | 95.74 mm | 95.74 mm | 95.74 mm |
Cash burn (monthly) | 5.03 mm | 7.77 mm | 4.67 mm | 8.53 mm | 5.03 mm | 7.88 mm |
Cash used (since last report) | 195.37 mm | 301.59 mm | 181.37 mm | 331.00 mm | 195.37 mm | 305.81 mm |
Cash remaining | -99.63 mm | -205.84 mm | -85.63 mm | -235.26 mm | -99.63 mm | -210.07 mm |
Runway (months of cash) | -19.8 | -26.5 | -18.3 | -27.6 | -19.8 | -26.7 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 33.10 mm |
Total shares | 15.81 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Tang Capital Partners | 12.96 mm | $30.19 mm |
BML Investment Partners | 2.85 mm | $2.91 mm |